Routine checks in PSC (Dr James Ferguson)
PSC is a complex condition and ideally, your care should be managed by someone with an interest in and experience of PSC. While there is no curative treatment, your doctor can monitor your condition and help manage your symptoms using current clinical practice guidelines for cholestatic liver diseases.
Because of the serious nature of the complications of PSC, you should remain under lifelong follow up with your PSC doctor (BSG/UK-PSC Guidelines Recommendation 4 58).
If you start to get more symptoms and your PSC is evolving or becoming complex, you should be referred for expert multi-disciplinary assessment. Patients with early, stable disease can be managed in general clinics (BSG/UK-PSC Guidelines Recommendation 16 58).
Your doctor will also discuss with you how he or she will manage your routine PSC healthcare and together you will form a PSC care plan and communicate this to your GP. Your GP should not be expected to know everything about PSC, and therefore it is helpful when your Hepatology/Gastroenterology consultant shares a clear picture of how you will be monitored and what role your GP will play.
Your PSC doctor will also give you information about what to do about concerns and how to contact the clinic.
Routine Care and Monitoring
Once PSC is diagnosed, your doctor will discuss with you and assess the following:
Cancer risk
Osteoporosis assessment (bone density)
Symptoms (such as itch, pain and fatigue)
Malabsorption of fat-soluble vitamins (in the case of more advanced PSC)
IBD screening
Clinical trials eligibility
Liver and bile ducts (extent of damage)
Related News
Use Your Voice to Shape the Future of Liver Transplant Allocation
As the only UK patient organisation dedicated to improving the lives of people affected by PSC we know how important it is for your voices to be heard. That’s why we’re sharing an opportunity for you to have your say in the current review of the National Liver Offering Scheme (NLOS).
Representing PSC Patients at the ERN RARE-LIVER Annual Meeting
Martine Walmsley, PSC Support Head of Research Strategy, represented patients with rare liver diseases at the ERN RARE-LIVER annual meeting.
Breaking News from ICR
Researchers at the Institute of Cancer Research (ICR) and St Mark’s Hospital in London have shared news today that they have developed a test to predict bowel cancer risk in people with inflammatory bowel disease.
First Participant in FARGO Trial
A PSC Support Trustee has been diagnosed with both PSC and inflammatory bowel disease (IBD). They is receiving weekly poo transplants to treat the conditions in a world first trial.
Important Patient Survey
Have you ever had a cholangitis attack? If so, please take this important survey today.
Quality of Your PSC Care
ERN RARE-LIVER survey results have been published. Thank you to the 939 people with PSC who took part in this survey.
Managing Your Care
Tips from Dr Andrew Yeoman on managing your healthcare at a time when our healthcare services are under increasing pressure to meet demands.
New European Guidelines for the care of People with PSC
A summary of the latest PSC care guidelines for Europe.
Ask the Expert Live Q&A with Dr Deepak Joshi 14 January 2023
Join us on 14 January 2023 for a live Q&A on all things PSc with Dr Deepak Joshi